Figure 1From: Incentives for new antibiotics: the Options Market for Antibiotics (OMA) modelNumber of New Molecular Entities Approved by the FDA per 5Â year period through March 2011. Source: [10]. By permission of Oxford University Press/on behalf of the Infectious Disease Society of America. Any reuse requires permission from Oxford University Press.Back to article page